Literature DB >> 7298125

Effect of age and spontaneous hypertension on the tachyphylaxis to 5-hydroxytryptamine and angiotensin II in the isolated rat kidney.

C De Mey, P M Vanhoutte.   

Abstract

The isolated and perfused kidney of the mature spontaneously hypertensive rat (SHR) exhibits an increased vascular reactivity and a delayed tachyphylaxis to 5-hydroxytryptamine, when compared to weight-matched normotensive animals. To evaluate the influence of the duration of the hypertensive state on these differences, the vascular reactivity to 5-hydroxytryptamine was determined in isolated kidneys from age-matched normotensive and spontaneously hypertensive rats of 3.5, 6 and 12 months of age. Responses to increasing doses of 5-hydroxytryptamine were compared. At all ages the responses to the agonist were greater in the SHR than in the control rats. In the normotensive rats, the sensitivity to the monoamine decreased, while the maximal response increased with aging. The vascular reactivity to increasing doses of 5-hydroxytryptamine was not altered by aging in the SHR. There was a significant correlation between the maximal vasoconstrictor response to 5-hydroxytryptamine in the isolated kidneys and the systolic arterial blood pressure (SBP) of the donor rats. Maximal constrictor responses to 5-hydroxytryptamine were repeated at given intervals. The degree of tachyphylaxis was decreased in hypertensive rats compared with normotensive rats at 3.5, and 6 months age. Tachyphylaxis to 5-hydroxytryptamine was depressed by aging in both normotensive and hypertensive rats. By contrast, tachyphylaxis to angiotensin II (AII) was not effected by either age or hypertension. There was no cross-tachyphylaxis between 5-hydroxytryptamine and AII. Lowering the Ca2+-concentration of the perfusate did not affect tachyphylaxis to either 5-hydroxytryptamine or AII. The present experiments indicate that the delayed tachyphylaxis to 5-hydroxytryptamine in the kidneys of SHR is due to a specific alteration of th vascular smooth muscle cells, which may be the consequence of premature aging.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7298125     DOI: 10.1161/01.hyp.3.6.718

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  6 in total

Review 1.  Role of reactive oxygen species in cardiovascular aging.

Authors:  C Muscari; A Giaccari; E Giordano; C Clô; C Guarnieri; C M Caldarera
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

2.  Serotonin metabolism and age-related effects of antihypertensive therapy with ketanserin.

Authors:  R Amstein; N Fetkovska; F Ferracin; A Pletscher; F R Bühler
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 3.  Serotonergic antagonists and vascular disease.

Authors:  P M Vanhoutte
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727

Review 4.  Serotonin and the vascular system. Role in health and disease, and implications for therapy.

Authors:  D S Houston; P M Vanhoutte
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

5.  Uridine adenosine tetraphosphate induces contraction and relaxation in rat aorta.

Authors:  A Elizabeth Linder; Michelle Tumbri; Felipe F P Linder; R Clinton Webb; Romulo Leite
Journal:  Vascul Pharmacol       Date:  2008-03-28       Impact factor: 5.773

6.  The direct and amplifying effects of serotonin are increased with age in the isolated perfused kidney of Wistar and spontaneously hypertensive rats.

Authors:  W J Janssens; J M Van Nueten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-12       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.